RxDoctor Payments Data

Louis Patrick Bell, DO

Family Medicine · Helena, ARNPI 1871589309

Payments from drug & device makers

$538in general payments, 2019–2025

Across 32 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$89
  • AstraZeneca$85
  • Abbott$78
  • Lilly USA, LLC$78
  • AbbVie$65
  • Novo Nordisk$32
  • plus $111 from 5 others

What the payments were for

  • Food & beverage$538100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$538 in reported general payments places this provider in the 45th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$9,589
Medicare patients
135
Services billed
338

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban129$95,788
MounjaroTirzepatide80$84,523
JardianceEmpagliflozin112$82,296
LinzessLinaclotide35$29,924
OzempicSemaglutide26$29,604
FarxigaDapagliflozin Propanediol29$27,737
XareltoRivaroxaban34$27,233
JanuviaSitagliptin Phosphate32$24,676
EntrestoSacubitril/Valsartan31$24,058
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$22,679
TrulicityDulaglutide16$15,729
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen445$9,050
Janumet XrSitagliptin Phos/Metformin Hcl15$6,574
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,084
Gabapentin392$4,107

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humulin 70-30$78$101,944111 claims
Boehringer IngelheimJardiance$25$82,296112 claims
AbbVieLinzess, Alphagan P$65$32,12047 claims
MerckJanuvia, Janumet Xr$28$31,25047 claims
Novo NordiskOzempic$32$29,60426 claims
GSKTrelegy Ellipta, Anoro Ellipta$89$27,76246 claims
AstraZenecaFarxiga$85$27,73729 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Helena

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →